Details
Stereochemistry | RACEMIC |
Molecular Formula | C9H13NO |
Molecular Weight | 151.2056 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N)CC1=CC(O)=CC=C1
InChI
InChIKey=WTDGMHYYGNJEKQ-UHFFFAOYSA-N
InChI=1S/C9H13NO/c1-7(10)5-8-3-2-4-9(11)6-8/h2-4,6-7,11H,5,10H2,1H3
Gepefrine (Pressionorm and Wintonin) is an antihypotensive agent. It was used for therapy of orthostatic dysregulation. One hour after oral administration of 30 mg or 45 mg gepefrine the blood pressure increased significantly at rest and more markedly on standing and during the step test. Gepefrine led to a reduction in pathological orthostatic regulation during the early phase as well as to the prevention of subjective and objective signs of orthostatic adjustment disorder during the late phase. Patients with insufficient rise in blood pressure during the step test (80 watts) showed after gepefrine a distinct tendency towards normalisation and the regression of subjective states of exhaustion. Gepefrine caused on average no substantive alternations in heart rate during all phases of the investigation. Complications or side-effects due to the method or the medicament were not observed.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0014061 Sources: https://www.ncbi.nlm.nih.gov/pubmed/13923440 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4002776
Curator's Comment: The action of the pressor agent gepefrine (D form of 3-hydroxyphenyl-2-aminopropan) was evaluated in 16 patients with typical clinical symptoms of orthostatic adjustment disorders
One hour after oral administration of 30 mg or 45 mg gepefrine the blood pressure increased significantly at rest and more markedly on standing and during the step test.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
102551
Created by
admin on Sat Dec 16 10:39:40 GMT 2023 , Edited by admin on Sat Dec 16 10:39:40 GMT 2023
|
PRIMARY | |||
|
1075-61-2
Created by
admin on Sat Dec 16 10:39:40 GMT 2023 , Edited by admin on Sat Dec 16 10:39:40 GMT 2023
|
PRIMARY | |||
|
214-056-0
Created by
admin on Sat Dec 16 10:39:40 GMT 2023 , Edited by admin on Sat Dec 16 10:39:40 GMT 2023
|
PRIMARY | |||
|
Gepefrine
Created by
admin on Sat Dec 16 10:39:40 GMT 2023 , Edited by admin on Sat Dec 16 10:39:40 GMT 2023
|
PRIMARY | |||
|
L9JB0763SW
Created by
admin on Sat Dec 16 10:39:40 GMT 2023 , Edited by admin on Sat Dec 16 10:39:40 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD